Monday, February 19, 2018

American Cancer Society Releases Position Statement on E-Cigs

The American Cancer Society just released the below position statement on e-cigs. This is a HUGE step forward in our fight to prove how much less harmful Vaping is than smoking! 
You can view the original statement HERE.

============

"American Cancer Society Position Statement on Electronic Cigarettes
The American Cancer Society Board of Directors approved the following position statement on electronic cigarettes (e-cigarettes) in February 2018. The position statement will be used to guide ACS’s tobacco control and cessation efforts as it relates to these products.

ACS Position Statement on Electronic Cigarettes
Combustible tobacco products, primarily cigarettes, are the single greatest cause of cancer and kill about 7 million people worldwide each year.  In the United States, 98% of all tobacco-related deaths are caused by cigarette smoking.  The U.S. tobacco landscape has changed rapidly in recent years, with millions of consumers now using electronic nicotine delivery systems (ENDS), the most prominent of which are electronic cigarettes (e-cigarettes).  E-cigarettes contain heated nicotine extracted from tobacco, as well as a variety of flavorings and other additives.

Scientific Summary: Based on currently available evidence, using current generation e-cigarettes is less harmful than smoking cigarettes, but the health effects of long-term use are not known.  The American Cancer Society (the ACS) recognizes our responsibility to closely monitor and synthesize scientific knowledge about the effects of all tobacco products, including e-cigarettes and any new products derived from tobacco.  As new evidence emerges, the ACS will promptly report these findings to policy makers, the public and clinicians.  

Clinical Recommendations: The ACS has always supported any smoker who is considering quitting, no matter what approach they use; there is nothing more important that they can do for their health.  To help smokers quit, the ACS recommends that clinicians advise their patients to use FDA-approved cessation aids that have been proven to support successful quit attempts. Many smokers choose to quit smoking without the assistance of a clinician and some opt to use e-cigarettes to accomplish this goal. The ACS recommends that clinicians support all attempts to quit the use of combustible tobacco and work with smokers to eventually stop using any tobacco product, including e-cigarettes.  Some smokers, despite firm clinician advice, will not attempt to quit smoking cigarettes and will not use FDA approved cessation mediations.  These individuals should be encouraged to switch to the least harmful form of tobacco product possible; switching to the exclusive use of e-cigarettes is preferable to continuing to smoke combustible products.  Of course, these individuals should be regularly advised to completely quit using all tobacco products.  The ACS strongly discourages the concurrent (or “dual”) use of e-cigarettes and combustible cigarettes, a behavior that is far more detrimental to a person’s health compared to the substantial health benefit of quitting smoking.

Policy Recommendations: The American Cancer Society recommends implementing polices and public health measures known to prevent the initiation and use of all tobacco products, including appropriate taxation, retail policies (e.g., raising the minimum age of purchase to 21), tobacco and e-cigarette aerosol-free policies and funding of evidence-based prevention and cessation programs.  The ACS strongly recommends that every effort be made to prevent the initiation of e-cigarettes by youth.  The use of products containing nicotine in any form among youth is unsafe and can harm brain development. Furthermore, evidence indicates that young e-cigarette users are at increased risk for both starting to smoke and becoming long-term users of combustible tobacco products.

The ACS encourages the FDA to regulate all tobacco products, including e-cigarettes, to the full extent of its authority, and to determine the absolute and relative harms of each product.  The FDA should assess whether e-cigarettes help to reduce tobacco-related morbidity and mortality, and the impact of marketing of e-cigarettes on consumer perceptions and behavior.  Any related regulatory regime should include post-marketing surveillance to monitor the long-term effects of these products and ensure the FDA’s actions have the intended health outcome of significantly reducing disease and death.  Furthermore, the FDA should use its authorities to reduce the toxicity, addictiveness and appeal of tobacco products currently on the market.  The ACS also applauds the FDA for recognizing its significant role as a science-based agency in helping to address the addictiveness of nicotine in cigarettes.  Reducing nicotine in all combustible tobacco products to below addictive levels holds the potential to significantly accelerate reductions in the use of combustible tobacco products, which remain by far the leading preventable cause of cancer and preventable death in the United States."


============

For up to date information follow The American Cancer Society online:

Monday, November 20, 2017

New Vaping Study Shows No Harm

Contact: Gregory Conley
Tel: 609-947-8059
Email: gconley@vaping.org
FOR IMMEDIATE RELEASE
November 20, 2017 at 9:30 AM

Landmark Long-Term Study on Vaping by Never-Smokers Finds No Negative Health Impacts


Despite fears of activists, no harm seen after three and a half years of vaping
LONDON, ENGLAND -- In a first of its kind long-term study published in the journal Nature, researchers have found no negative health impacts from the daily use of electronic cigarettes by young adult never-smokers.

Researchers from the University of Catania, led by Dr. Riccardo Polosa, tracked nine electronic cigarette users with no history of smoking, as well as twelve lifetime non-smokers and non-vapers, over the course of three and a half years. The researchers found no impact on a variety of health outcomes, including blood pressure, heart rate, lung function, exhaled breath nitric oxide, exhaled carbon monoxide, and CT scans of the lungs. 

“In spite of previous health scares, our study shows for the first time no risk in long-term vapers who have never smoked in their life,” said Polosa, who presented the study at the fifth annual E-Cigarette Summit in the United Kingdom on Friday, November 17th.

Polosa notes that while even longer-term research is needed to rule out any possible negative impacts, changes in spirometry and CT scans can be seen in young smokers after approximately two years of cigarette usage. With the vapers, no signs of lung damage, including COPD, lipoid pneumonia, and popcorn lung, were found in CT scans, even among the study participants with the highest consumption of e-liquid.

In the United States, far less than 1% of adult never-smokers are current vapers, with an even smaller proportion reporting vaping daily, according to the CDC’s 2015 National Health Interview Survey. Despite this, much of the concern in the media and scientific circles revolve around fears of the impact of vaping on nonsmokers. 

“Mouse and cell studies may generate salacious headlines about the supposed dangers of vaping, but they are no replacement for studies on actual humans,” said Gregory Conley, President of the American Vaping Association, a nonprofit that advocates for truthful information about vapor products. “If no negative health impacts can be seen from daily vaping among those who previously did not smoke, how is it ethical to continue warning smokers away from using these products?” 

In addition to this groundbreaking research, Polosa also recently published a review of the evidence on the impact of vapor products on COPD patients.
# # #
About the American Vaping Association

The American Vaping Association is a nonprofit organization that advocates for policies that encourage the growth and sustainability of small- and medium-sized businesses in the rapidly growing vaping and electronic cigarette industry. The AVA was founded by Gregory Conley, a consumer and industry advocate with a long track record of advocating for vapor products dating back to 2010.

We are dedicated to educating the public and government officials about public health benefits offered by vapor products, which are battery-powered devices that heat a liquid nicotine or nicotine-free solution and create an inhalable vapor.  The AVA is not a trade group and does not speak for any particular businesses, including our industry sponsors.

You can learn more about AVA and vaping by visiting the AVA website. You can also find us on FacebookTwitter, and Instagram.